2016 POGO Symposium on Childhood Cancer

The 2016 POGO Symposium on Childhood Cancer – Leukemia: Successes, Advances, Challenges examined clinical and scientific advances in the diagnosis and treatment of leukemia in children and adolescents and highlighted the impact of this disease on patients, parents and survivors.

Over 300 health professionals representing a variety of disciplines attended the conference, which sold out!


Click on the session titles below to view presentations that POGO has permission to share. 

NOTE: The content of each presentation below captures the unedited information and opinions presented by the speakers. Please note that the information contained in the presentations was current at the time it was presented – there may be further information in subsequent literature. Listed speaker credentials were current at the time of presentation.

The Long and Winding Road – A Brief History of Pediatric Leukemia
Stephen Sallan, MD

Managing Behavioural Changes During and After Treatment for Leukemia
Nina Kadan-Lottick, MD, MSPH

Quick Hits:
1. Immunizations – Marina Salvadori, MD, FRCPC
2. KiCS and PROFYLE: Precision Medicine Initiatives – David Malkin, MD, FRCPC
3. Minimal Residual Disease (MRD) Evaluation in Childhood ALL: A Health Policy Analysis – Nicole Bradley, MHSc

Implications of Treatment for ALL on Attention, Memory, and Learning
Sharon Guger, PhD

Asparaginase: The Good, the Bad and the Ugly
Paul Gibson, MD, FRCPC
Lee Dupuis, RPh., PhD
Stephen Sallan, MD 

Toxicity Management: Supportive Care Options for Children with Leukemia
Lillian Sung, MD 

Future Targets for Acute Myeloid Leukemia (AML)
Edward Anders Kolb, MD

Pain, Fatigue and Obesity: Managing Chronic Complications while on Therapy and Beyond
Ellen Lavoie Smith, PhD, APRN, AOCN, FAAN
Steven Mittelman, MD, PhD
Sue Zupanec, MN, NP-Pediatrics

Caring Beyond the Cure: Long-term Outcomes in Survivors of Childhood Leukemia
Paul Nathan, MD, MSc, FRCPC

The Future of Leukemia Therapy
Ching-Hon Pui, MD

Workshop A – Biology, Diagnosis and Treatment of Rare Leukemias
Jeff Lipton, PhD, MD, FRCPC
Mignon Loh, MD
Jim Whitlock, MD

Workshop B – Leukemia in the Down Syndrome Population
Kim S. Daniel, M.Ed, PhD
Johann Hitzler, MD
Jeffrey W. Taub, MD

Workshop C – Staying the Course: Addressing Compliance Challenges in the Treatment of Pediatric Leukemia
Wendy Landier, PhD, CRNP
Mark D. Minden, PhD, MD, FRCPC

Workshop D – Tiny Patients, Enormous Challenges: Treatment Approaches for Infant ALL
Patrick Brown, MD
Jennifer Drynan-Arsenault, BSc, BScPhm, RPh, ACPR
Krista Johnston, BScPT, MScPT(c) 

Comments are closed.